DK162889C - Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater - Google Patents
Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparaterInfo
- Publication number
- DK162889C DK162889C DK009390A DK9390A DK162889C DK 162889 C DK162889 C DK 162889C DK 009390 A DK009390 A DK 009390A DK 9390 A DK9390 A DK 9390A DK 162889 C DK162889 C DK 162889C
- Authority
- DK
- Denmark
- Prior art keywords
- frames
- preparation
- hexahydrodaminededozeozepine
- undertakings
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8701636 | 1987-07-15 | ||
| PCT/US1987/001636 WO1989000561A1 (en) | 1987-07-15 | 1987-07-15 | Fused benzazepines |
| EP87110253A EP0299101B1 (en) | 1987-07-15 | 1987-07-16 | Fused benzazepines |
| EP87110253 | 1987-07-16 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK9390D0 DK9390D0 (da) | 1990-01-12 |
| DK9390A DK9390A (da) | 1990-03-12 |
| DK162889B DK162889B (da) | 1991-12-23 |
| DK162889C true DK162889C (da) | 1992-05-11 |
Family
ID=26108265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK009390A DK162889C (da) | 1987-07-15 | 1990-01-12 | Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0363353B1 (cs) |
| JP (1) | JPH0678317B2 (cs) |
| AT (1) | ATE78467T1 (cs) |
| AU (1) | AU617651B2 (cs) |
| DE (1) | DE3780649T2 (cs) |
| DK (1) | DK162889C (cs) |
| ES (1) | ES2043623T3 (cs) |
| FI (1) | FI93212C (cs) |
| GR (1) | GR3006671T3 (cs) |
| HU (1) | HU203537B (cs) |
| NO (1) | NO177264C (cs) |
| WO (1) | WO1989000561A1 (cs) |
| ZA (1) | ZA875183B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4973586A (en) | 1986-01-16 | 1990-11-27 | Schering Corporation | Fused benzazepines, compositions of, and medical use thereof |
| PL168787B1 (pl) * | 1989-08-03 | 1996-04-30 | Smithkline Beecham Biolog | Sposób wytwarzania czastki kompozytowej PL |
| JPH0613474B2 (ja) * | 1990-02-02 | 1994-02-23 | シェリング・コーポレーション | ４，５―シクロアルカノ―３―ベンズアゼピン―７―オール誘導体およびその使用 |
| JPH07137816A (ja) * | 1993-11-15 | 1995-05-30 | Tokai Univ | 地下空洞内貯蔵装置 |
| MXPA05002249A (es) * | 2002-08-29 | 2005-06-08 | Schering Corp | Antagonistas selectivos del receptor d1/d5 para el tratamiento de obesidad y trastornos del sistema nervioso central. |
| CA2526017A1 (en) * | 2003-05-22 | 2005-04-21 | Schering Corporation | 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3393192A (en) * | 1965-04-26 | 1968-07-16 | Schering Corp | Novel benzazepines |
| CH481110A (de) * | 1967-02-17 | 1969-11-15 | Geigy Ag J R | Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen |
| US4680298A (en) * | 1983-05-31 | 1987-07-14 | Schering Corporation | Tricyclic anti-allergy and use as anti-inflammatory agents |
| JPH0681745B2 (ja) * | 1986-01-16 | 1994-10-19 | シェリング・コ−ポレ−ション | 縮合ベンゾアゼピン |
-
1987
- 1987-07-15 AU AU80378/87A patent/AU617651B2/en not_active Ceased
- 1987-07-15 JP JP62506016A patent/JPH0678317B2/ja not_active Expired - Lifetime
- 1987-07-15 EP EP87906614A patent/EP0363353B1/en not_active Expired - Lifetime
- 1987-07-15 AT AT87906614T patent/ATE78467T1/de not_active IP Right Cessation
- 1987-07-15 WO PCT/US1987/001636 patent/WO1989000561A1/en active IP Right Grant
- 1987-07-15 ZA ZA875183A patent/ZA875183B/xx unknown
- 1987-07-15 DE DE8787906614T patent/DE3780649T2/de not_active Expired - Lifetime
- 1987-07-15 HU HU8552A patent/HU203537B/hu not_active IP Right Cessation
- 1987-07-16 EP EP87110253A patent/EP0299101B1/en not_active Expired - Lifetime
- 1987-07-16 ES ES87110253T patent/ES2043623T3/es not_active Expired - Lifetime
-
1990
- 1990-01-12 FI FI900175A patent/FI93212C/fi not_active IP Right Cessation
- 1990-01-12 NO NO900186A patent/NO177264C/no unknown
- 1990-01-12 DK DK009390A patent/DK162889C/da active
-
1992
- 1992-12-24 GR GR920403109T patent/GR3006671T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI900175A0 (fi) | 1990-01-12 |
| DK162889B (da) | 1991-12-23 |
| JPH02504629A (ja) | 1990-12-27 |
| GR3006671T3 (cs) | 1993-06-30 |
| NO900186D0 (no) | 1990-01-12 |
| DE3780649D1 (de) | 1992-08-27 |
| EP0299101B1 (en) | 1992-09-23 |
| AU617651B2 (en) | 1991-12-05 |
| HU203537B (en) | 1991-08-28 |
| ATE78467T1 (de) | 1992-08-15 |
| EP0299101A1 (en) | 1989-01-18 |
| DK9390A (da) | 1990-03-12 |
| NO177264B (no) | 1995-05-08 |
| NO177264C (no) | 1995-08-16 |
| ZA875183B (en) | 1988-04-08 |
| EP0363353A1 (en) | 1990-04-18 |
| FI93212C (fi) | 1995-03-10 |
| ES2043623T3 (es) | 1994-01-01 |
| JPH0678317B2 (ja) | 1994-10-05 |
| DE3780649T2 (de) | 1992-12-10 |
| WO1989000561A1 (en) | 1989-01-26 |
| FI93212B (fi) | 1994-11-30 |
| DK9390D0 (da) | 1990-01-12 |
| EP0363353B1 (en) | 1992-07-22 |
| AU8037887A (en) | 1989-02-13 |
| NO900186L (no) | 1990-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE148114T1 (de) | Fluor substituierte benzocycloheptapyridine, zusammensetzungen und verfahren zur verwendung derselben als antihistaminische verbindungen | |
| BR9407910A (pt) | Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto | |
| NO302884B1 (no) | Krystallinske 3,4,4-trisubstituert-piperidinyl-N-alkylkarboksylater og mellomprodukter, fremgangsmåte for fremstilling av de krystallinske karboksylatene, farmasöytiske preparater inneholdende disse og deres anvendelse | |
| DK94783A (da) | Fremgangsmaade til fremstilling af kvaternaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl-norscopinethere og mellemprodukter herfor | |
| ATE293595T1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| DK0532515T3 (da) | Fremstilling af substituerede piperidiner | |
| WO1987004430A3 (en) | Fused benzazepines | |
| DK0614362T3 (da) | Farmaceutiske præparater på basis af ebastin og dermed analoge forbindelser | |
| PT80752B (pt) | Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas | |
| DK0638068T3 (da) | Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner | |
| DK162889C (da) | Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| DE69300551D1 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
| DK0536197T3 (da) | Ren, krystallinsk form af rifapentine | |
| DK0422566T3 (da) | Fremgangsmåde til fremstilling af 3-(L-pyroglutamyl)-L-thiazolidin-4-carboxylsyre og derivater deraf | |
| DE59105224D1 (de) | Verfahren zur Herstellung von N-substituierten Pyrrolidonen. | |
| NO930205L (no) | Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK0840724T3 (da) | Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre | |
| FI951091L (fi) | Uudet alkyyliaminoindaaniyhdisteet, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| DE69327693D1 (de) | Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen | |
| DK0635490T3 (da) | Fremgangsmåde til fremstilling af N-ethylcarbazol | |
| DK0519512T3 (da) | Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre | |
| DE59105920D1 (de) | Verfahren zur Herstellung von 5-Hydroxy-3,4,5,6-tetrahydro-pyrimidin-Derivaten. | |
| DK0761657T3 (da) | Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater | |
| DE58906998D1 (de) | Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin. |